AbbVie operates four state-of-the-art facilities in the United States, complementing our global manufacturing presence, including our operations headquarters just north of Chicago. Embedded in the rich, advanced pharmaceutical industry of the United States, AbbVie’s US contract manufacturing facilities provide a vast assortment of contract manufacturing capabilities.
Our mainland US locations are well positioned to access sustainable local and raw material resources thanslating into cost effective production of APIs and drug products. AbbVie is committed to meeting US and European cGMP manufacturing standards in all four facilities, which are located in:
AbbVie's has a network of manufacturing facilities around the world to support your project and project needs. See AbbVie's other locations for additional manufacturing site information and technical expertise.
AbbVie's Lake County facility is situated 40 miles north of Chicago, Illinois. This location is also AbbVie’s global operations headquarters. This facility manufactures and packages finished drug product, with specific expertise at producing tablets, capsules, liquid-filled capsules, granules, prefilled syringes and oral liquids.
AbbVie’s Lake County facility manufactures nearly one billion tablets and capsules per year, along with packaging almost 3 billion solid dosages per year in total. Site inspection includes accreditation by the FDA, Irish Medicines Board (IMB) and the National Health Surveillance Agency (ANVISA).
AbbVie’s Lake County contract manufacturing expertise:
AbbVie's North Chicago facility is situated just minutes away from our Lake County headquarters, approximately 40 miles north of Chicago. This location is where our company's pioneering history in pharmaceutical development began. The facility manufactures many of our active pharmaceutical ingredients (APIs) through fermentation processes and offers pilot scale to full commercial production.
Customers benefit from our 60+ years of extensive fermentation and regulatory expertise. Beyond domestic FDA regulatory accreditation, additional inspections and clearances include the National Health Surveillance Agency Brazil (ANVISA), Japan and Germany.
AbbVie’s North Chicago, US cGMP manufacturing expertise:
The AbbVie Bioresearch Center (ABC) is a Worcester facility 42 miles west of central Boston, Massachusetts. It is our premier biologics research and development center, and features more than 400,000 ft2 of dedicated biologics manufacturing space. The facility offers process design, analytical characterization and cGMP manufacturing for the development and commercialization of biopharmaceutical active pharmaceutical ingredients (APIs).
AbbVie’s Worcester contract manufacturing expertise:
AbbVie's Wyandotte facility is located approximately 10 miles south of Detroit, Michigan and 20 minutes from Detroit Metro Airport. This facility specializes in active pharmaceutical ingredients (APIs) and intermediates. It has a highly configurable multipurpose train, with an on-site synthesis and characterization laboratory.
AbbVie’s Wyandotte, US cGMP manufacturing also offers controlled drug security.
AbbVie’s Wyandotte contract manufacturing expertise:
To discuss how these technologies can benefit your drug development program, contact AbbVie today.
AbbVie maintains a range of regional and global regulatory standards to meet guidelines enforced in your country of origin, and those of your intended markets.